Answers are grounded in this paper and cite their sources.
Review shows colchicine may reduce cardiovascular events in patients at risk, indicating its potential benefit in secondary prevention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ebrahimi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: